ALTANA SUBMITS NDA FOR NASAL SPRAY

Altana has announced that the FDA has accepted for filing the company's new drug application (NDA) for Ciclesonide nasal spray.

A new drug submission for Ciclesonide nasal spray was also submitted to Health Canada. Altana is seeking marketing approval for the treatment of nasal symptoms associated with seasonal and perennial allergic rhinitis.